By using bispecific antibodies targeting a tumor-associated antigen (TAA) on the cancer cells, and CD3 on the T-cells, it is possible to redirect and activate any circulating T-cells against tumor cells independently of the specificity of their TCR. Thanks to the bridging action of such TAAxCD3 bsAb, T-cells are brought in close proximity of the target cancer cells, leading to subsequent T-cell activation and T-cell–mediated killing of the tumor cells.
For more information on T-cell redirecting κλ-bodies, please visit Light Chain Bioscience.
Read our latest news
Human papillomavirus (HPV) is the most common viral sexually transmitted disease . Most sexually active individuals will become infected at some point in their lives. Of those infections, about 90% are asymptomatic and resolve spontaneously . Additionally, some...
We are delighted to announce that a new publication featuring Nanolive imaging has been published in BMC Molecular and Cell Biology. The study, a huge international collaboration spearheaded by Dr. Michael Cahill from the Charles Sturt University (NSW, Australia) and...
Dr. Yakimovich and colleagues from the Greber group based at the University of Zurich, published a scientific paper that described how Nanolive imaging can be used to visualize the cytopathic (structural changes) effects that different viruses have on host cells...
3D CELL EXPLORER
Budget-friendly, easy-to-use, compact solution for high quality non-invasive 4D live cell imaging
3D CELL EXPLORER-fluo
Multimodal Complete Solution: combine high quality non-invasive 4D live cell imaging with fluorescence